Interestingly, a splicing mutation that produces a C-terminal truncated RECQ4 protein (R766X) similar to that of Q757X mutation has been reported as a recurrent hotspot in the tumor registry and considered oncogenic (cBioPortal cBioPortal. This evidence concerns the gene RECQL4 and neoplasm.